Unlock instant, AI-driven research and patent intelligence for your innovation.

Composition and application of borneol combined with neurotrophic factors

A technology of ciliary neurotrophy and borneol, which is applied in the direction of drug combination, active ingredients of hydroxyl compounds, drug delivery, etc., can solve the problems of no retinal disease treatment, achieve good drug compliance, increase safety and convenience, and promote distribution effect

Active Publication Date: 2020-12-18
艾视科(苏州)生物工程有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But at present, borneol and other traditional Chinese medicine prescriptions are used for the treatment of conjunctivitis and keratitis, but not for the treatment of retinal diseases.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition and application of borneol combined with neurotrophic factors
  • Composition and application of borneol combined with neurotrophic factors
  • Composition and application of borneol combined with neurotrophic factors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1 Borneol CNTF eye drops preparation

[0039] (1) Gel matrix eye drop sample preparation: Weigh 1.0 g of carboxymethylcellulose sodium (CMC-Na), add 50 g of water for injection, stir to make it evenly dispersed, leave it at room temperature overnight, add the remaining 49 g of water for injection, Stir for 5-10 min, and let stand to obtain 1% CMC-Na gel matrix for later use.

[0040] (2) Weigh 1.336g of polyoxyethylene hydrogenated castor oil 40 (RH40), 0.334g of polyethylene glycol 400 (PEG400), stir for 10min and mix evenly for later use;

[0041] (3) Weigh 0.025g of borneol and add it to step (2), stir to make it completely dissolve;

[0042] (4) Weigh 200 μg of CNTF and dissolve it in 2 mL of phosphate-buffered saline (PBS), and set aside;

[0043] Add (3) and (4) into 10g of 1% CMC-Na gel, stir for 10min to disperse evenly, then add 86.105g of 1%CMC-Na several times in small amounts, stir to disperse evenly, and adjust the pH If the value is 6.0-8.0, ...

Embodiment 2

[0045] Example 2 Effects of Different Concentrations of Borneol on CNTF Retinal Distribution

[0046] Experimental animal New Zealand rabbits were randomly divided into 6 groups, normal saline group, borneol eye drops group, CNTF eye drops group, different concentrations of borneol CNTF eye drops groups (borneol concentration 0.025%, 0.05%, 0.1%), respectively. 50 μL of the corresponding eye drops were instilled in the eyes, before the administration (0h) and 15 minutes, 30 minutes, 1 hour, and 2 hours after the administration, 5 rabbits were randomly selected in each group to be killed and the retinas were taken, and the enzyme-linked immunosorbent assay was used to (ELISA) method was used to detect the content of CNTF in retinal tissue, and each sample was set up with three duplicate wells, and the average value was taken. The results showed that after administration for 15 minutes, the CNTF content determination results of the borneol group and the blank group were 2.8±0.0p...

Embodiment 3

[0049] Example 3 Effect of Borneol CNTF Eye Drops on Retinal Function in Rats with Retinal Degeneration

[0050] Using 40mg / kg sodium iodate tail vein injection to induce retinal degeneration rat model, the rats after modeling were randomly divided into normal saline group, borneol eye drop group, CNTF eye drop group, borneol CNTF eye drop group, Normal SD rats were fed routinely as a control, and the drug was administered 4 times a day, 10 μL each time. After 14 days of administration, the retinal function was detected by electroretinogram (ERG). Rats were dark-adapted to general anesthesia combined with local anesthesia and mydriasis. Animal warmers were used. Rat-specific circular corneal electrodes were used to elicit retinal integrated potentials with standard flash stimulation. by retinal electricity Figure five Item measurement, record value. Including scotopic ERG, maximal mixed response, oscillatory potentials (OPs), photopic condition ERG, flicker light ERG. turn...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a borneol and neurotrophic factor combined composition and an application thereof and belongs to the technical field of eye disease treatment. The borneol and neurotrophic factor combined composition includes borneol and a neurotrophic factor, wherein the neurotrophic factor includes one or more of a ciliary neurotrophic factor, a brain-derived neurolmphic factor, a nerve growth factor, a neurenergen family and a glial cell line-derived neurotrophic factor; meanwhile, this application also researches an application of the borneol and neurotrophic factor combined composition to retinal degeneration injury and specifically relates to an application of the borneol and the various neurotrophic factors to preparation of drugs and pharmaceutical compositions, and the borneol and neurotrophic factor combined composition may be used for treating retinal degeneration injury diseases including primary retinitis pigmentosa, age-related macular degeneration, rod and cone dystrophy and retinal ganglion cell damage caused by intraocular hypertension and the like.

Description

technical field [0001] The invention belongs to the technical field of treatment of ophthalmic diseases, and relates to a composition of borneol combined with neurotrophic factors and its application, more specifically, to the application of a composition of borneol combined with neurotrophic factors in retinal degeneration and injury. Background technique [0002] Retinal degeneration is a group of serious blinding eye diseases, the most common of which are age-related macular degeneration (age-related macular degeneration, AMD) and retinitis pigmentosa (RP). There is still no effective treatment for the disease. The common pathological basis of these diseases is the irreversible damage of retinal neurons, so neuroprotection is the key to preventing retinal degeneration. [0003] Neurotrophic factors are a class of proteins that play an important role in the development, survival and apoptosis of neurons, and its members include ciliary neurotrophic factor (CNTF), brain-de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/18A61K31/045A61K9/00A61K9/08A61K47/44A61K47/38A61P27/02
CPCA61K9/0019A61K9/0048A61K9/08A61K31/045A61K38/185A61K47/38A61K47/44A61P27/02A61K2300/00
Inventor 梁丽娜张晶许凯刘淑芝杜茂波
Owner 艾视科(苏州)生物工程有限公司